Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinically applicable mutation screening in familial hypercholesterolemia

H Nissen1, P Guldberg, A B Hansen

  • 1Department of Clinical Chemistry, Odense University Hospital, Denmark.

Human Mutation
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of litter amount and seed sowing position on seedling emergence and growth of hemiparasitic Rhinanthus species under drought stress.

Plant biology (Stuttgart, Germany)·2024
Same author

DIAGNOSIS OF ENDOCRINE DISEASE: Sex steroid action in adolescence: too much, too little; too early, too late.

European journal of endocrinology·2020
Same author

Recent advances in solid oxide cell technology for electrolysis.

Science (New York, N.Y.)·2020
Same author

Pulmonary arteriovenous malformations: a radiological and clinical investigation of 136 patients with long-term follow-up.

Clinical radiology·2018
Same author

Current perspectives in the interpretation of gunshot residues in forensic science: A review.

Forensic science international·2016
Same author

Consumption of and satisfaction with health care among opioid users with chronic non-malignant pain.

Acta anaesthesiologica Scandinavica·2015

A new denaturing gradient gel electrophoresis (DGGE) assay accurately identifies mutations causing familial hypercholesterolemia (FH) and familial defective apo B-100 (FDB). This sensitive method aids in precise diagnosis and improved patient management.

Area of Science:

  • Genetics
  • Molecular Biology
  • Biochemistry

Background:

  • Familial hypercholesterolemia (FH) and familial defective apo B-100 (FDB) are clinically similar genetic disorders caused by mutations in the LDLR or apo B-100 genes, respectively.
  • Traditional diagnostic methods for FH can be inaccurate, hindering precise prognostic evaluation and genetic counseling.
  • Existing genetic screening methods are often too complex for routine clinical application.

Purpose of the Study:

  • To develop a rapid, sensitive, and clinically applicable mutation screening assay for FH and FDB.
  • To improve diagnostic accuracy and facilitate differentiated prognostic and therapeutic evaluations for affected families.

Main Methods:

  • A novel mutation screening assay utilizing denaturing gradient gel electrophoresis (DGGE) was designed.

Related Experiment Videos

  • The assay targets the LDLR promoter, all 18 LDLR exons and splice sites, and the codon 3500 region of apo B-100.
  • Identified mutation hotspots are subsequently confirmed by sequencing.

    • Main Results:

    • The DGGE-based assay can pinpoint mutation locations within 24 hours.
    • The assay demonstrated high sensitivity, detecting 27 different mutations and polymorphisms across the targeted regions (excluding LDLR exon 16).

    Conclusions:

    • A simple, sensitive, and clinically applicable DGGE mutation screening assay can identify the underlying genetic cause in most FH/FDB families.
    • This assay provides a valuable tool for more accurate prognostic and therapeutic management of patients with FH and FDB.